JUN 14, 2020 8:10 AM PDT

Amping Up Immunity to Respiratory Viruses by Targeting Memory T Cells in the Lungs

WRITTEN BY: Carmen Leitch

While we've learned that infection with the SARS-CoV-2 virus, which causes COVID-19, can cause problems in many organ systems, the lungs can sustain significant damage in many severe cases. Researchers are trying to learn more about how immune cells in the lungs react to the virus, which could inform the development of a vaccine for SARS-CoV-2 and other viruses. Scientists at the Salk Institute have now learned that it's easier than thought to activate immune cells that reside in the lungs and are involved in long-term immunity. The findings have been reported in the Journal of Experimental Medicine.

Lung-specific CD8 killer T cells (blue) in lung tissue (green) surrounded by dendritic lung cells (red). / Credit: Salk Institute

"Inside our lungs exist long-lived killer T cells that recognize specific viruses and protect us against reinfection, should we encounter the virus again. Our results have elucidated the manner by which these cells see the virus upon reinfection and provide rapid immunity," said the study leader, Salk Professor Susan Kaech, director of Salk's NOMIS Center for Immunobiology and Microbial Pathogenesis. "It also may help us understand long-term immunity as it relates to coronavirus."

If our body is exposed to a pathogenic invader like the flu virus, a type of immune cell called killer T cells can destroy these invaders, or take on a memory of them so that if there is a second encounter with the pathogen, the T cells can react more quickly. This is (a simplification of) how our body establishes long-term immunity, and vaccines take advantage of the process by giving the immune system just enough of exposure so that it will have the capacity to fight the pathogen if an infection ever happens.

While researchers know about the activation of memory T cells in organs like the lymph nodes, for example, dendritic cells are known to play an important in T cell activation in part by exposing the T cells to fragments of the pathogen. Less is known about whether or how this happens in some other organs like the lungs.

In this study, the researchers used a mouse model to remove various types of dendritic cells one at a time to see whether the memory T cells in the lungs would recognize a second infection.

"At first, our results were disappointing because it didn't seem like our experiments were working; the killer memory T cells in the lungs continued to recognize the virus after the deletion of many different messenger cell types," said first study author Jun Siong Low, now a postdoctoral fellow at the Institute for Research in Biomedicine (IRB) at the Università della Svizzera Italiana, in Switzerland. "Soon, we realized that these lung-resident killer memory T cells were special because they were not reliant on any single type of messenger cell. Instead, they could see the second influenza infection through a variety of different messenger cells, including non-immune cells like lung epithelial cells, which was a remarkably exciting finding."

Memory T cells in the lymph nodes need dendritic cells to react to a second exposure to a virus, so the physical location of memory T cells seems to dictate how they are reactivated. When they are infected, almost any kind of cell can reactivate memory T cells, suggesting that vaccines that work on the memory T cells in the lungs may be especially effective.

"We will take this knowledge into our next study, where we will examine whether lung-resident killer memory T cells form after a coronavirus infection," said Kaech. "Since not all infections induce killer memory T cells, we will determine if these cells form after a coronavirus infection and whether they can be protective against future coronavirus infections."

Sources: AAAS/Eurekalert! via Salk Institute, Journal of Experimental Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
NOV 10, 2020
Immunology
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
NOV 10, 2020
Genetic Profiling Reveals How Ebola Puts Immune Cells in a Chokehold
In the middle of 2020, yet another deadly Ebola outbreak was reported in the Democratic Republic of the Congo - the 11th ...
NOV 12, 2020
Immunology
The Enzyme That Keeps Viruses In Stealth Mode
NOV 12, 2020
The Enzyme That Keeps Viruses In Stealth Mode
Some viral infections just don’t go away. The hepatitis C virus, for instance, can result in life-long chronic inf ...
NOV 30, 2020
Microbiology
Common Antibiotic Could be Effective Zika Treatment
NOV 30, 2020
Common Antibiotic Could be Effective Zika Treatment
Zika virus cause a devastating epidemic in 2015, and led to the birth of hundreds of children that had congenital brain ...
DEC 24, 2020
Microbiology
A New, Infectious Strain of SARS-CoV-2 Emerges
DEC 24, 2020
A New, Infectious Strain of SARS-CoV-2 Emerges
The UK recently reported that it had detected a new variant of the SARS-CoV-2 pandemic virus, which causes COVID-19. Thi ...
JAN 06, 2021
Immunology
Probiotic Boosters Are Lifesavers for Preterm Babies
JAN 06, 2021
Probiotic Boosters Are Lifesavers for Preterm Babies
When administered shortly after birth, a recent study has found that the supplementation combo of probiotics and prebiot ...
JAN 08, 2021
Cell & Molecular Biology
How Viruses Keep the Infection Going
JAN 08, 2021
How Viruses Keep the Infection Going
There has long been debate about whether viruses are a form of life, because many of them are only made up of a bit of g ...
Loading Comments...